- Thomson Medical's results were below expectations. FY25 revenue was 93% of our forecast. Adjusted net loss of S$26.8mil was wider than our forecasted S$4.3mil net loss.
- - Read this at SGinvestors.io -
- Growth is returning to Singapore as case complexity and revenue intensity rise. Malaysia has turned profitable in 4Q25 as discounting eases.
- The valuation of the Johor land bank is raised to S$1.5bn from S$1bn. Gross development value target of RM18bn is in-line with our modelled RM17bn.
The Positive
Growth returning to Singapore.
- - Read this at SGinvestors.io -
The Negative
Softness in Vietnam.
- Read more at SGinvestors.io.